Some major asthma inhaler manufacturers announced $35 a month caps on out-of-pocket costs. The price cap will apply to people with commercial/private insurance (through your job or federal or state marketplace) or no insurance. If you have government-funded insurance (such as Medicare, Medicaid, or Tricare), you won’t qualify for a price cap, but you may qualify for a patient assistance program that can reduce what you pay. The inhalers that will be price capped include: AstraZeneca…
Quelle: Asthma and Allergy Foundation of America
Artikel: What You Need to Know About the $35 Price Cap on Asthma Inhalers
Titelbild/Grafik: Asthma and Allergy Foundation of America (AAFA)
Möchten Sie zu diesem Inhalt ein Kommentar abgeben oder haben Sie dazu eine Frage, dann machen Sie dies bitte immer auf der Herausgeberseite!
Quick-Links
Aktuelles von Asthma and Allergy Foundation of America
- Can’t Smell After a Nasal Polyp Diagnosis? You Are Not Alone
- October Research Update: New Approvals for Chronic Hives and Eczema Treatments
- What the Government Shutdown Means for Your Health Insurance Costs
- Indoor Air Quality and Its Impact on School Children with Asthma
- Eczema: Know the Facts
- Content Warning: Is Pollen a Risk Factor for Suicide?
- Hives (Urticaria): Know the Facts
- Mother and Daughter Tackle Asthma with Positivity and a Fighting Spirit
- Improving Asthma Outcomes During the September Asthma Peak
- 5 Facts About the 2025-2026 Flu and COVID-19 Vaccines
